deltatrials
Completed PHASE1 INTERVENTIONAL 1-arm NCT00005807

Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer (BMS-247550)

A Phase I Scientific Exploratory Study of Epothilone B Analog in Patients With Solid Tumors and Gynecological Malignancies

Sponsor: Albert Einstein College of Medicine

Conditions Breast Cancer Ovarian Cancer Unspecified Adult Solid Tumor, Protocol Specific
Interventions BMS-247550
Updated 9 times since 2017 Last updated: Oct 5, 2018 Started: Jul 31, 2000 Primary completion: Aug 31, 2004 Completion: Aug 31, 2004
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00005807, this PHASE1 trial focuses on Breast Cancer and Ovarian Cancer and remains completed. Sponsored by Albert Einstein College of Medicine, it has been updated 9 times since 2000, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshotCompleted~Nov 2018 – ~Feb 2019 · 3 months · monthly snapshotCompleted~Feb 2019 – ~Jan 2021 · 23 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE1

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  5. Feb 2019 — Jan 2021 [monthly]

    Completed PHASE1

▶ Show 4 earlier versions

  1. Nov 2018 — Feb 2019 [monthly]

    Completed PHASE1

  2. Jun 2018 — Nov 2018 [monthly]

    Completed PHASE1

  3. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE1

  4. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE1

    First recorded

Jul 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Albert Einstein College of Medicine
  • National Cancer Institute (NCI)
Data source: Albert Einstein College of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations